Lantheus Holdings LNTH shares are trading higher after the company received FDA approval of PYLARIFY injection.
Lantheus is currently up 15.06% to a price of $22.32. Thursday the stock has been traded at a volume of 4.70 million, about 642.3% of its recent 30-day volume average of 731.50 thousand.
The 50-day moving average price of Lantheus Holdings's stock was $21.28 when this article was published. The stock reached a high of $24.26 and a low of $10.52 in the past 52 weeks.
If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.